David Fitzgerald

Biography

David has broad experience in both private equity and mergers and acquisitions. David’s primary focus has been on the healthcare, information technology, and business services sectors. Prior to joining Petra, David was a General Partner at Richland Ventures, a venture capital fund with $340 million in assets under management. Earlier in his career, David led market development and acquisition activities for InformDx, a diagnostic laboratory company and THG Management Services, a managed healthcare company. David received a Bachelor of Arts degree from Washington & Lee University.

Research Interest

David has board-level experience with many successful growth companies including SpecialtyCare (sold to American Securities), US Healthworks (sold to Dignity Health), Televox (sold to West Corp.), Appriss (sold to Bain Capital), Synhrgy (sold to Mercer), Nuvox Communications (sold to Windstream), Salveo Specialty Pharmacy (sold to Catamaran). He currently serves as a director on the boards of Urgent Team, New Century Hospice, Opportune IT Healthcare Solutions, Access Media 3, SUN Behavioral Health, Clinipace Worldwide, VirMedica, and Lineagen.